I tend to think the news out of acadia is going to get better, their ceo seems to be motivated to make things happen for daybue. I'm looking forward to their update later this month as I think it could be a significant catalyst for neu going forward.
- Forums
- ASX - By Stock
- NEU
- Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.23%
!
$12.26

Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.26 |
Change
-0.280(2.23%) |
Mkt cap ! $1.525B |
Open | High | Low | Value | Volume |
$12.45 | $12.45 | $11.88 | $6.952M | 570.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 231 | $12.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.32 | 1979 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 231 | 12.260 |
1 | 3000 | 12.250 |
2 | 3451 | 12.200 |
1 | 1579 | 12.190 |
3 | 3885 | 12.180 |
Price($) | Vol. | No. |
---|---|---|
12.320 | 1979 | 2 |
12.330 | 1885 | 2 |
12.340 | 1579 | 1 |
12.360 | 2001 | 1 |
12.370 | 1579 | 1 |
Last trade - 16.13pm 23/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |